Science & Technology
Development of Inhibitors Against SARS CoV-2 NSP16 Methyltransferase
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AI177149-01A1
Award Ceiling
$600K
Award Floor
$600K
Close Date
Mar 31, 2026
16 days leftTotal Funding
$600K
Expected Awards
1
Posted Date
Apr 10, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AI177149-01A1
Description
STTR Phase Phase I award: "Development of Inhibitors Against SARS CoV-2 NSP16 Methyltransferase" awarded to LYCHEE BIOSCIENCE LLC in TUCSON, Arizona. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $599,970. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.